ROMVIMZA™

Advertisement

cGxPJobs Banner

EU Approves ROMVIMZA™, First Therapy for TGCT Patients in Europe

Brussels, Belgium – September 17, 2025 – In a landmark development for rare disease patients, the European Commission (EC)...

By cGxPwire Editor
September 18, 2025

Read More

Advertisement

cGxPJobs

Directory